Perspectives of individuals with sickle cell disease on barriers to care.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 23 08 2021
accepted: 01 03 2022
entrez: 23 3 2022
pubmed: 24 3 2022
medline: 4 5 2022
Statut: epublish

Résumé

Sickle cell disease (SCD) is an inherited hemoglobinopathy that predominantly affects African Americans in the United States. The disease is associated with complications leading to high healthcare utilization rates, including emergency department (ED) visits and hospitalizations. Optimal SCD care requires a multidisciplinary approach involving SCD specialists to ensure preventive care, minimize complications and prevent unnecessary ED visits and hospitalizations. However, most individuals with SCD receive sub-optimal care or are unaffiliated with care (have not seen an SCD specialist). We aimed to identify barriers to care from the perspective of individuals with SCD in a multi-state sample. We performed a multiple methods study consisting of surveys and interviews in three comprehensive SCD centers from March to June 2018. Interviews were transcribed and coded, exploring themes around barriers to care. Survey questions on the specific themes identified in the interviews were analyzed using summary statistics. We administered surveys to 208 individuals and conducted 44 in-depth interviews. Barriers to care were identified and classified according to ecological level (i.e., individual, family/interpersonal, provider, and socio-environmental/organizational level). Individual-level barriers included lack of knowledge in self-management and disease severity. Family/interpersonal level barriers were inadequate caregiver support and competing life demands. Provider level barriers were limited provider knowledge, provider inexperience, poor provider-patient relationship, being treated differently, and the provider's lack of appreciation of the patient's SCD knowledge. Socio-environmental/organizational level barriers included limited transportation, lack of insurance, administrative barriers, poor care coordination, and reduced access to care due to limited clinic availability, services provided or clinic refusal to provide SCD care. Participants reported several multilevel barriers to SCD care. Strategies tailored towards reducing these barriers are warranted. Our findings may also inform interventions aiming to locate and link unaffiliated individuals to care.

Identifiants

pubmed: 35320302
doi: 10.1371/journal.pone.0265342
pii: PONE-D-21-27336
pmc: PMC8942270
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0265342

Subventions

Organisme : NINR NIH HHS
ID : K23 NR017899
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL133996
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Am Acad Nurse Pract. 2009 May;21(5):250-7
pubmed: 19432908
Am J Public Health. 2016 Apr;106(4):591-2
pubmed: 26959254
Issues Ment Health Nurs. 2018 Aug;39(8):675-686
pubmed: 29652215
Health Educ Q. 1988 Winter;15(4):351-77
pubmed: 3068205
J Pediatr Hematol Oncol. 2009 Aug;31(8):571-6
pubmed: 19636266
Prof Case Manag. 2018 Jul/Aug;23(4):213-219
pubmed: 29846351
J Adolesc Health. 2010 May;46(5):407-13
pubmed: 20413075
Ann Hematol. 2020 Nov;99(11):2497-2505
pubmed: 32869184
Soc Sci Med. 2012 Jun;74(11):1712-20
pubmed: 22361090
JAMA. 2010 Apr 7;303(13):1288-94
pubmed: 20371788
J Natl Med Assoc. 2009 Oct;101(10):1022-33
pubmed: 19860302
Am J Prev Med. 2016 Jul;51(1 Suppl 1):S87-98
pubmed: 27320471
N Engl J Med. 2013 Jan 3;368(1):6-8
pubmed: 23281971
Public Health Rep. 2019 Nov/Dec;134(6):599-607
pubmed: 31600481
JAMA Netw Open. 2020 May 1;3(5):e206016
pubmed: 32469413
PLoS One. 2019 May 7;14(5):e0216414
pubmed: 31063506
J Behav Med. 2002 Jun;25(3):269-83
pubmed: 12055777
Blood Adv. 2020 Sep 22;4(18):4463-4473
pubmed: 32941646
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Ann Emerg Med. 2020 Sep;76(3S):S64-S72
pubmed: 32928465
Pediatrics. 2002 Mar;109(3):526-35
pubmed: 11875155
Int J Hematol Ther. 2015;1(1):
pubmed: 26900602
J Adv Nurs. 2016 Jun;72(6):1441-51
pubmed: 26350494
Med Care. 2017 Mar;55(3):207-214
pubmed: 27579910
Am J Hematol. 2011 Oct;86(10):863-5
pubmed: 21815184
N Engl J Med. 1994 Jun 9;330(23):1639-44
pubmed: 7993409
Am J Hematol. 2013 Jun;88(6):532-3
pubmed: 23526459
ANS Adv Nurs Sci. 2014 Oct-Dec;37(4):287-98
pubmed: 25365282
Glob Pediatr Health. 2019 May 03;6:2333794X19847026
pubmed: 31106244
Am J Hematol. 2018 Dec;93(12):E391-E395
pubmed: 30203558
Anemia. 2012;2012:492428
pubmed: 22701785
J Adv Nurs. 2016 Jun;72(6):1417-29
pubmed: 26370255
J Racial Ethn Health Disparities. 2018 Feb;5(1):117-140
pubmed: 28275996
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Lancet. 2010 Dec 11;376(9757):2018-31
pubmed: 21131035
Patient Educ Couns. 2014 Aug;96(2):159-64
pubmed: 24935607
Am J Prev Med. 2010 Apr;38(4 Suppl):S512-21
pubmed: 20331952
Pediatr Blood Cancer. 2013 May;60(5):828-35
pubmed: 23335275

Auteurs

Shannon Phillips (S)

College of Nursing, Medical University of South Carolina, Charleston, SC, United States of America.

Yumei Chen (Y)

Department of Hematology/Oncology, UCSF Benioff Children's Hospital Oakland, Oakland, CA, United States of America.

Rita Masese (R)

School of Nursing, Duke University, Durham, NC, United States of America.

Laurence Noisette (L)

Department of Pediatrics, Medical University of South Carolina, Charleston, SC, United States of America.

Kasey Jordan (K)

College of Nursing, Medical University of South Carolina, Charleston, SC, United States of America.

Sara Jacobs (S)

Translational Health Research Division, RTI International, Research Triangle Park, NC, United States of America.

Lewis L Hsu (LL)

Department of Pediatrics, Comprehensive Sickle Cell Center, University of Illinois at Chicago, Chicago, IL, United States of America.

Cathy L Melvin (CL)

Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, United States of America.

Marsha Treadwell (M)

Department of Pediatrics/Division of Hematology, UCSF Benioff Children's Hospital Oakland, Oakland, CA, United States of America.

Nirmish Shah (N)

School of Medicine, Duke University, Durham, NC, United States of America.

Paula Tanabe (P)

School of Nursing, Duke University, Durham, NC, United States of America.

Julie Kanter (J)

Division of Hematology & Oncology, University of Alabama at Birmingham, Birmingham, AL, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH